IL6 and atherosclerosis: Persistent low-grade inflammation, characterized by moderate increases in circulating pro-inflammatory cytokines (C-reactive protein: CRP; interleukins (IL): IL-6, IL-2, IL-7, IL-8, etc.), plays a significant role in all atherosclerosis formation and progression phases.